TABLE 4.
Pharmaceutical expenditures of continued drugs by 12 ATC 1-level groups during the period 2010–2019 (%).
| 2010–2011 vs. 2012–2013 | 2012–2013 vs. 2014–2015 | 2014–2015 vs. 2016–2017 | 2016–2017 vs. 2018–2019 | Annual average | (Change) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price | Quantity | Mixed | Price | Quantity | Mixed | Price | Quantity | Mixed | Price | Quantity | Mixed | Price | Quantity | Mixed | Price | Quantity | Mixed | |
| Total | −16.34 | 21.66 | −7.55 | −6.51 | 10.69 | 1.63 | −2.19 | 8.21 | 7.74 | −3.04 | 11.22 | 6.48 | −3.5 | 6.5 | 1.0 | (−71) | (131) | (21) |
| A | −9.30 | −1.35 | −0.38 | −0.44 | 8.81 | 2.81 | 2.93 | 2.61 | −0.78 | −0.26 | −0.19 | −0.03 | −1.4 | 2.1 | −0.2 | −29 | 43 | −3 |
| B | 0.67 | −1.14 | −0.25 | −0.32 | −0.64 | 2.38 | 1.92 | 1.89 | 0.06 | −0.22 | −0.12 | −0.02 | −0.1 | 0.7 | 0.0 | −3 | 14 | −1 |
| C | 0.44 | −0.82 | −0.41 | −0.64 | −0.41 | 1.72 | 3.20 | 3.80 | 0.04 | −0.16 | −0.20 | −0.05 | −0.2 | 1.0 | 0.0 | −4 | 21 | −1 |
| D | −0.51 | 0.12 | −0.07 | 0.02 | 0.48 | −0.25 | 0.54 | −0.11 | −0.04 | 0.02 | −0.03 | 0.00 | −0.1 | 0.1 | 0.0 | −1 | 2 | 0 |
| G | 0.34 | −0.58 | −0.06 | −0.13 | −0.32 | 1.21 | 0.44 | 0.77 | 0.03 | −0.11 | −0.03 | −0.01 | −0.1 | 0.3 | 0.0 | −1 | 5 | 0 |
| H | 0.66 | −0.02 | −0.02 | −0.02 | −0.63 | 0.03 | 0.14 | 0.14 | 0.06 | 0.00 | −0.01 | 0.00 | 0.1 | 0.0 | 0.0 | 2 | −1 | 0 |
| J | −8.89 | −0.50 | −0.09 | 0.10 | 8.42 | 1.05 | 0.71 | −0.56 | −0.74 | −0.10 | −0.05 | 0.01 | −1.2 | 1.2 | −0.1 | −24 | 24 | −2 |
| L | 5.51 | −0.72 | −0.33 | −0.68 | −5.22 | 1.50 | 2.58 | 4.00 | 0.46 | −0.14 | −0.17 | −0.05 | 0.5 | 0.4 | 0.0 | 10 | 7 | 0 |
| M | −4.59 | −0.28 | −0.10 | −0.17 | 4.34 | 0.58 | 0.79 | 1.03 | −0.38 | −0.05 | −0.05 | −0.01 | −0.6 | 0.8 | −0.1 | −13 | 17 | −1 |
| N | 1.77 | −0.86 | −0.22 | −0.39 | −1.67 | 1.79 | 1.69 | 2.32 | 0.15 | −0.16 | −0.11 | −0.03 | 0.0 | 0.5 | 0.0 | 1 | 10 | 0 |
| P | −0.12 | 0.00 | 0.00 | 0.00 | 0.11 | −0.01 | 0.00 | 0.00 | −0.01 | 0.00 | 0.00 | 0.00 | 0.0 | 0.0 | 0.0 | 0 | 0 | 0 |
| R | −1.65 | −0.29 | −0.08 | −0.11 | 1.56 | 0.60 | 0.62 | 0.65 | −0.14 | −0.06 | −0.04 | −0.01 | −0.3 | 0.4 | 0.0 | −5 | 9 | −1 |
| S | −0.68 | −0.25 | −0.12 | −0.18 | 0.65 | 0.52 | 0.96 | 1.05 | −0.06 | −0.05 | −0.06 | −0.01 | −0.2 | 0.4 | 0.0 | −3 | 8 | −1 |
| V | 2.40 | −0.03 | −0.07 | −0.05 | −2.27 | 0.07 | 0.53 | 0.32 | 0.20 | −0.01 | −0.03 | 0.00 | 0.3 | −0.2 | 0.0 | 6 | −3 | 0 |
Notes: Changes were calculated as the annual average (based on 7 decimal points).
A, Alimentary Tract and Metabolism.
B, blood and blood-forming organs.
C, cardiovascular system.
G, dermatologicals.
H, genitourinary system and sex hormones.
J, systemic hormonal preparations, excl. sex hormones, and insulins.
M, anti-infectives for systemic use.
N, antineoplastic and immunomodulating agents.
R, musculoskeletal system.
D, nervous system.
L, antiparasitic products, insecticides, and repellents.
p, respiratory system.
S, sensory organs.
V, various.